Call for Research Program Applications for the Years 2007-2011
The central goal of the Research Programs of The Faculty of Medicine has been to promote interaction and collaboration between basic and clinical research on the Meilahti medical campus and surroundings. This endeavor commenced in 2001, and it encompassed six Research Programs in the Biomedicum Helsinki building. After their initial five-year period, the programs were evaluated by the Scientific Advisory Board (SAB) in November 2005. The SAB stated that the Research Program structure is working very well indeed. Nevertheless, their recommendation was that only two of the current programs should continue for the next five-year period and that despite excellent research components in two other Research Programs, these latter programs were advised and encouraged to reapply with more focused plans for 2007-2011.
Definition of a Research Program
A Research Program should comprise a number of successful research groups from different disciplines and focus on a common goal of (bio)medical importance. The program should represent an interphase between basic and clinical research and include both basic scientists and physician-scientists. Program size is not important; the keys to the success are cohesiveness and excellence in research and training. In addition, the programs are anticipated to participate in the development and maintenance of research infrastructure on the Meilahti medical campus as well as be involved in undergraduate teaching.
In its additional comments, the SAB stated that the Faculty of Medicine should have at least five Research Programs located in the Biomedicum Helsinki building. However, location of the programs is not restricted to this site, and other space available to the Faculty of Medicine could also be considered. It should be emphasized that the final number of Research Programs will be strictly dependent on the quality of the proposals.
Application Procedure and Selection of New Research Programs
The dead-line for proposals of new Research Program is April 1, 2006. New five-year programs will be selected for the years 2007-2011. The Research Council of the Faculty of Medicine will organize the process, and scientific evaluation of the proposals will be conducted by the SAB chaired by Professor Erkki Ruoslahti. The evaluation by the SAB is anticipated to take place by the end of May 2006, and the decision pertaining to the selection of new Research Programs be made by the end of June 2006. The decision on final space allocation for all the Programs will be made in September 2006.
Each Research Program proposal should have the general structure described below. In addition, should the Research Programs evaluated in November 2005 elect to reapply, their proposal has to commence with a response/rebuttal (max. 2 pages) to the comments of the SAB.
Structure of the Application
New Research Program proposal written in English has to include the description of the structure, research and training activities and goals, together with other pertinent information as outlined below. Please adhere to the page limitations shown in parentheses. (Use font Times Roman, size 12, single spacing.)
1. Name of the program, the Program Director, the Group Leaders, and abstract (1 page)
2. Research groups and their previous accomplishments (all together 2 pages)
3. Synergy and added value of the program
• Synergy, cohesion and added value (1 page)
• Interaction between basic and clinical research and the plans to promote it (1 page)
• Past collaboration among the proposed program members (1 page)
• Management structure of the program (1 page)
4. Scientific goals of the program
• Background and significance (1 page)
• Specific aims (0.5 page)
• Description of the approaches to address the aims (4 pages)
• Expected achievements and their ramifications (1 page)
5. Research training and career development of young scientists
• Graduate student training, involvement in graduate schools (1 page)
• Training of postdoctoral fellows (0.5 page)
• Training courses (0.5 page)
6. Contribution to infrastructure
• Current and future activities (1 page)
• Special technical expertise within the program and development of new technologies (1 page)
7. Space requirements
• Suggestions for location and space in Biomedicum Helsinki and in other space available to the Faculty of Medicine (1 page)
Should the space not be physically contiguous, special description of the means to achieve cohesiveness within the program is required (1 page).
8. Curriculum vitae
• CVs of the Program Director and the Group Leaders
The CVs (3 pages each) should include 10 selected publications from 1996-2006; the names of the scientific staff and their affiliations (Scientists, Postdoctoral Fellows and Graduate Students); the names of Ph.D. recipients in 1996-2006 and their current positions; a list of main collaborators; and current funding.
9. Funding of the program
• Expected funding of the entire program in 2007-2011
Funding information should be broken down according to the source:
• University of Helsinki (including salaries)
• Academy of Finland
• Private foundations
• Funding from other ministries
• EU (list projects, indicate the type: IP, NoE, STREP)
• Other international sources
The proposal should be delivered as a single Word document by April 1, 2006, to Kirmo Wartiovaara (email@example.com). The Research Council of the Faculty of Medicine will arrange several questions-answers events for potential applicants on the Meilahti campus in February-March 2006.
Chair of Research Council of the Faculty of Medicine
University of Helsinki
Scientific Advisory Board
Professor Erkki Ruoslahti, The Burnham Institute (chair)
Professor Elizabeth Barrett-Connor, University of California at San Diego
Professor Anders Björklund, Lund University, Lund
Professor Elisabetta Dejana, Istituto di Ricerche Farmacologiche Mario Negri, Milan
Professor Eliane Gluckman, Hôpital Saint Louis, Paris
Professor Ele Ferrannini, University of Pisa, Pisa
Professor Helen H. Hobbs, University of Texas Southwestern, Dallas
Professor Robert W. Mahley, University of California, San Francisco
Professor Ueli Schibler, University of Geneva, Geneva
Professor Alan L. Schwartz, Washington University School of Medicine, St. Louis
Professor Kai Simons, Max Planck Institute for Molecular Cell Biology and Genetics, Dresden
Professor Timothy A. Springer, Harvard Medical School, Boston
Professor Axel Ullrich, Max-Planck-Institut für Biochemie, Martinsried